Physician profile
John D Miles
NPI 1710970306
$15,214.07
in general payments reported to CMS, 2019-2025
14 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,210 · 2020: $2,477 · 2021: $2,498 · 2022: $3,368 · 2023: $767 · 2024: $2,707 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,950 · Travel and Lodging: $1,117 · Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,950.00 |
| Travel and Lodging | $1,117.12 |
| Food and Beverage | $594.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $10,764.81 | 2019-2024 | Simplify Cervical Artificial Disc, Elsa, Coalition Mis / Mis Ti |
| Mml US, INC. | $2,781.23 | 2022-2025 | Reactiv8 |
| Nuvasive, INC. | $1,278.29 | 2019-2023 | Simplify Cervical Artificial Disc |
| Cerapedics INC. | $125.82 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Zsfab, INC. | $53.52 | 2023 | |
| Pacira Therapeutics, INC. | $40.07 | 2019-2020 | |
| Abbott Laboratories | $36.64 | 2023 | Proclaim |
| Sanofi-Aventis U.S. LLC | $27.23 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $24.30 | 2025 | Iovera |
| Vertex Pharmaceuticals Incorporated | $23.32 | 2025 | |
| Si-Bone, INC. | $19.87 | 2019 | |
| Pfizer INC. | $15.12 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.06 | 2020 | |
| Fidia Pharma USA INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.